» Articles » PMID: 7843268

Estimates of Antagonist Affinities at P2X Purinoceptors in Rat Vas Deferens

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 1994 Oct 3
PMID 7843268
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In functional studies pyridoxalphosphate-6-azophenyl-2',5'-disulphonic acid (iso-PPADS), suramin, GR200282 (4,4'-[carbonyl-bis(imino-3- benzoylimino)]-bis[5-hydroxy-naphthalene-2,7-disulfonic acid] tetrapotassium salt), cibacron blue, trypan blue and congo red, each produced specific antagonism of the contractile responses of isolated rat vas deferens, induced by alpha,beta-methylene ATP (alpha,beta-meATP), with antagonist pKB estimates of 6.6 +/- 0.3, 5.5 +/- 0.2, 5.1 +/- 0.3, 5.8 +/- 0.2, 4.7 +/- 0.2 and 4.6 +/- 0.2, respectively. In radioligand binding studies, iso-PPADS, suramin, cibacron blue, GR200282, trypan blue and congo red competed for the high affinity [3H]alpha,beta-meATP binding sites in rat vas deferens membranes with pKi estimates of 5.6 +/- 0.04, 5.5 +/- 0.08, 5.6 +/- 0.15, 5.6 +/- 0.04, 4.3 +/- 0.06 and 4.9 +/- 0.10, respectively. Comparison of pKB and pKi estimates revealed a good agreement between the two approaches for estimating measures of affinity for the putative antagonists, except in the case of iso-PPADS. However, we found that two populations of [3H]alpha,beta-meATP binding sites can be identified by iso-PPADS, 26.4% of these having low affinity (pKi of 4.4 +/- 0.2), and 73.6% having high affinity (pKi of 6.5 +/- 0.02) for iso-PPADS. The pKi of 6.5 obtained at the high affinity sites identified by iso-PPADS was close to the equivalent pKB value of 6.6 from functional studies. These studies therefore show a good agreement between pKB and pKi estimates for several antagonists, and suggest that the high affinity binding sites labelled with [3H]alpha,beta-meATP in rat vas deferens represents binding to functional P2X purinoceptors.

Citing Articles

Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.

Kim Y, Brown S, Harden T, Boyer J, Dubyak G, King B J Med Chem. 2001; 44(3):340-9.

PMID: 11462975 PMC: 10790710. DOI: 10.1021/jm9904203.


Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed.

Gitterman D, Evans R Br J Pharmacol. 2001; 131(8):1561-8.

PMID: 11139432 PMC: 1572518. DOI: 10.1038/sj.bjp.0703760.


Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.

King B, Liu M, Pintor J, Gualix J, Miras-Portugal M, Burnstock G Br J Pharmacol. 1999; 128(5):981-8.

PMID: 10556935 PMC: 1571720. DOI: 10.1038/sj.bjp.0702876.


New insights on P2X purinoceptors.

Humphrey P, Buell G, Kennedy I, Khakh B, Michel A, Surprenant A Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(6):585-96.

PMID: 9053729 DOI: 10.1007/BF00171316.


Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.

Michel A, Grahames C, Humphrey P Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(5):562-71.

PMID: 8938653 DOI: 10.1007/BF00170829.